- Home
- ARWR vs AES Comparison
ARWR vs AES Comparison
Compare ARWR & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | AES |
|---|---|---|
| Founded | 2003 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.1B |
| IPO Year | 1993 | 1991 |
Fundamental Metrics
Financial Performance| Metric | ARWR | AES |
|---|---|---|
| Price | $67.01 | $14.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $63.70 | $15.56 |
| AVG Volume (30 Days) | 2.4M | ★ 6.9M |
| Earning Date | 02-09-2026 | 11-04-2025 |
| Dividend Yield | N/A | ★ 4.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | $829,448,000.00 | ★ $12,094,000,000.00 |
| Revenue This Year | N/A | $1.22 |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | $9.46 |
| Revenue Growth | ★ 23258.15 | N/A |
| 52 Week Low | $9.57 | $9.46 |
| 52 Week High | $72.36 | $15.51 |
Technical Indicators
Market Signals| Indicator | ARWR | AES |
|---|---|---|
| Relative Strength Index (RSI) | 60.22 | 59.65 |
| Support Level | $65.94 | $13.36 |
| Resistance Level | $69.71 | $14.02 |
| Average True Range (ATR) | 3.16 | 0.29 |
| MACD | -1.04 | 0.08 |
| Stochastic Oscillator | 56.15 | 83.33 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.